Parasympathomimetics donepezil

The initial enthusiasm for tacrine and velnacrine, which are the anticholinesterases most studied clinically, has been tempered by the fact that not all patients respond. Most show the peripheral parasympathomimetic effects of cholinesterase inhibition, e.g. dyspepsia and diarrhoea, as well as nausea and vomiting, and about half of the patients develop hepatotoxicity with elevated levels of plasma alanine transaminase. While some peripheral effects can be attenuated with antimuscarinics that do not enter the brain, these add further side-effects and the drop-out rate from such trials is high (<75%) in most long-term studies. Donepezil appears to show less hepatotoxicity but its long-term value remains to be determined. 

DONEPEZIL SUXAMETHONIUM Possible t efficacy of suxamethonium Suxamethonium is metabolized by cholinesterase parasympatho-mimetics inhibit cholinesterase and so prolong the action of suxamethonium Avoid co-administration. Ensure that the effects of suxamethonium have worn off before administering a parasympathomimetic to reverse non-depolarizing muscle relaxants. A careful risk-benefit analysis should be made before considering the use of suxamethonium for emergency anaesthesia in patients taking parasympathomimetics. The short half-life of edrophonium means that it can be used to diagnose suspected dual block with suxamethonium... 

---